Ovarian Tissue Transplantation: Experience From Germany and Worldwide Efficacy
- PMID: 31431803
- PMCID: PMC6685107
- DOI: 10.1177/1179558119867357
Ovarian Tissue Transplantation: Experience From Germany and Worldwide Efficacy
Abstract
Extraction of ovarian tissue prior to oncologic therapy and subsequent transplantation is being performed increasingly often to preserve fertility in women. The procedure can be performed at any time of the cycle and, therefore, generally does not lead to any delay in oncological therapy. Success rates with transplantation of cryopreserved ovarian tissue have reached promising levels. More than 130 live births have been reported worldwide with the aid of cryopreserved ovarian tissue and the estimated birth rate is currently approximately 30%. In Germany, Austria, and Switzerland, the FertiPROTEKT consortium has successfully achieved 21 pregnancies and 17 deliveries generated after 95 ovarian tissue transplantations by 2015, one of the largest case series worldwide confirming that ovarian tissue cryopreservation and transplantation are successful. Approximately, more than 400 ovarian tissue cryopreservation procedures are performed each year in the FertiPROTEKT consortium, and the request and operations for ovarian tissue transplantation have increased in recent years. Therefore, recommendations for managing transplantation of ovarian tissue to German-speaking reproductive medicine centers were developed. In this overview, these recommendations and our experience in ovarian tissue transplantation are presented and discussed with international procedures.
Keywords: FertiPROTEKT; Fertility preservation; gonadotoxic treatment; ovarian tissue cryopreservation; ovarian tissue transplantation; pregnancy after chemotherapy.
Conflict of interest statement
Declaration of conflicting interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures


Similar articles
-
Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates.Hum Reprod. 2016 Sep;31(9):2031-41. doi: 10.1093/humrep/dew165. Epub 2016 Jul 4. Hum Reprod. 2016. PMID: 27378768
-
Concept Paper on the Technique of Cryopreservation, Removal and Transplantation of Ovarian Tissue for Fertility Preservation.Geburtshilfe Frauenheilkd. 2019 Jan;79(1):53-62. doi: 10.1055/a-0664-8619. Epub 2018 Oct 9. Geburtshilfe Frauenheilkd. 2019. PMID: 30686834 Free PMC article.
-
Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy--a technique in its infancy but already successful in fertility preservation.Eur J Cancer. 2009 Jun;45(9):1547-53. doi: 10.1016/j.ejca.2009.01.029. Epub 2009 Mar 4. Eur J Cancer. 2009. PMID: 19264478 Review.
-
Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis.Hum Reprod. 2014 Sep;29(9):1931-40. doi: 10.1093/humrep/deu158. Epub 2014 Jun 22. Hum Reprod. 2014. PMID: 24958067
-
Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease.Oncologist. 2007 Dec;12(12):1437-42. doi: 10.1634/theoncologist.12-12-1437. Oncologist. 2007. PMID: 18165621 Review.
Cited by
-
Comparison of open and a novel closed vitrification system with slow freezing for human ovarian tissue cryopreservation.J Assist Reprod Genet. 2021 Oct;38(10):2723-2733. doi: 10.1007/s10815-021-02297-9. Epub 2021 Aug 16. J Assist Reprod Genet. 2021. PMID: 34398400 Free PMC article.
-
Oocyte collection and outcome following oncologic treatment: a retrospective multicentre study.Support Care Cancer. 2024 May 29;32(6):390. doi: 10.1007/s00520-024-08586-0. Support Care Cancer. 2024. PMID: 38806697 Free PMC article.
-
Applying plastic surgery principles to ovarian tissue transplantation.Gland Surg. 2021 Jul;10(7):2266-2274. doi: 10.21037/gs-21-24. Gland Surg. 2021. PMID: 34422597 Free PMC article. Review.
-
Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis.Hum Reprod Update. 2022 May 2;28(3):400-416. doi: 10.1093/humupd/dmac003. Hum Reprod Update. 2022. PMID: 35199164 Free PMC article.
-
Installing oncofertility programs for breast cancer in limited versus optimum resource settings: Empirical data from 39 surveyed centers in Repro-Can-OPEN Study Part I & II.J Assist Reprod Genet. 2022 Feb;39(2):505-516. doi: 10.1007/s10815-022-02394-3. Epub 2022 Jan 15. J Assist Reprod Genet. 2022. PMID: 35032286 Free PMC article.
References
-
- Dittrich R, Kliesch S, Schüring A, et al. Fertility preservation for patients with malignant disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017)—recommendations and statements for girls and women. Geburtshilfe Frauenheilkd. 2018;78:567-584. - PMC - PubMed
-
- Jadoul P, Guilmain A, Squifflet J, et al. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases. Hum Reprod (Oxford, England). 2017;32:1046-1054. - PubMed
-
- Lotz L, Maktabi A, Hoffmann I, Findeklee S, Beckmann MW, Dittrich R. Ovarian tissue cryopreservation and retransplantation—what do patients think about it. Reprod Biomed Online. 2016;32:394-400. - PubMed
-
- Donnez J, Garcia-Solares J, Dolmans MM. Ovarian endometriosis and fertility preservation: a challenge in 2018. Minerva Ginecol. 2018;70:408-414. - PubMed
LinkOut - more resources
Full Text Sources